Many diploid rose species and cultivars possess valuable traits that can be introgressed into modern tetraploid cultivars. Interspecific, interploidy crosses are possible, but triploid hybrids typically have limited fertility, hindering further breeding and selection. Tetraploidizing diploids before mating with tetraploids can alleviate fertility barriers. The efficiency of trifluralin was investigated for polyploidization of Rosa chinensis minima (2n = 2x = 14) seedlings. Treatments were trifluralin at 0.086% and 0.0086%, colchicine (0.5%), and distilled water and contained 2% dimethyl sulfoxide and a surfactant. Approximately 5 µl of the treatment solution was applied to the apical meristem of seedlings (N = 337, 82-85 per treatment) in the process of cotyledon expansion. Guard cell length, pollen diameter, and root tip squashes of rooted cuttings were used to detect polyploidy in meristematic layer (L)I, LII, and LIII, respectively. Trifluralin (0.086%) was the most effective treatment for polyploidization (LI 20.2%, LII 12.9%, LIII 12.9%), followed by trifluralin (0.0086%) (LI 10.6%, LII 7.1%, LIII 4.7%) and colchicine (LI 2.4%, LII 0%, LIII 0%). Polyploidization consistently occurred from LI inward. Polyploids as a group had reduced pollen stainability and a lower leaflet length to width ratio than diploids. In addition, two diploid seedlings were identified which produce 2n pollen. Considerations in selecting germplasm and generating somatically-induced polyploids from seedlings versus clones for use in breeding are discussed.
Rose black spot, caused by Diplocarpon rosae, is one of the most devastating foliar diseases of cultivated roses (Rosa spp.). The globally distributed pathogen has the potential to cause large economic losses in the outdoor cultivation of roses. Fungicides are the primary method to manage the disease, but are often viewed unfavorably by home gardeners due to potential environmental and health impacts. As such, rose cultivars with genetic resistance to black spot are highly desired. The tetraploid climbing rose Brite EyesTM (‘RADbrite’) is known for its resistance to black spot. To better characterize the resistance present in Brite EyesTM, phenotyping was conducted on a 94 individual F1 population developed by crossing Brite EyesTM to the susceptible tetraploid rose ‘Morden Blush’. Brite EyesTM was resistant to all D. rosae races evaluated except for race 12. The progeny were either resistant or susceptible to all races (2, 3, 8, 9, 10, 11, and 13) evaluated. The segregation ratio was 1:1 (χ2 = 0.3830, P = 0.5360) suggesting resistance is conferred by a single locus. The roses were genotyped with the WagRhSNP 68K Axiom array and the ‘polymapR’ package was used to construct a map. A single resistance locus (Rdr4) was identified on the long arm of chromosome 5 homoeolog 4. Three resistance loci have been previously identified (Rdr1, Rdr2, and Rdr3). Both Rdr1 and Rdr2 are located on a chromosome 1 homoeolog. The chromosomal location of Rdr3 is unknown, however, races 3 and 9 are virulent on Rdr3. Rdr4 is either a novel gene or an allele of Rdr3 as it provides resistance to races 3 and 9. Due to its broad resistance, Rdr4 is an excellent gene to introgress into new rose cultivars.
Additional index words. rose chromosome count, rose disease, fungal isolate, Diplocarpon rosae pathogenic race Abstract. Regional, replicated cultivar trials of landscape roses are an ongoing component of the Earth-Kind Ò program, which was started at Texas A&M University in the 1990s to support environmental landscape stewardship. The rose trials within the Earth-Kind program identify and promote the most regionally adapted rose cultivars and are conducted without fertilizers or pesticides and greatly reduced irrigation. Black spot (caused by Diplocarpon rosae Wolf) is the most serious disease of outdoor-grown roses worldwide as a result of the potential for rapid leaf yellowing and defoliation. Earth-Kind designated cultivars for the south-central United States and roses under trial in other regions or considered for future Earth-Kind trials (n = 73 roses) and two susceptible control cultivars were challenged with North American Races 3, 8, and 9 of D. rosae, which were previously characterized at the University of Minnesota. Young expanded leaves were inoculated using detached leaf assays. Lesion length (LL) was measured for susceptible reactions and cultivar ploidy was determined using root tip squashes. Diploid, triploid, and tetraploid cultivars (n = 20, 30, and 23, respectively) were identified, and race-specific resistances and partial resistances were also identified. Race-specific resistance was generally more prevalent in newer rose cultivars and rose cultivars more recently included in Earth-Kind trials. Nine cultivars were resistant to all three races (Brite Eyesä, 'Grouse', Home Run Ò , Knock Out Ò , Paprikaä, Peachy Creamä, Pink Knock Out Ò , Rainbow Knock Out Ò , and Yellow Submarineä). Blushing Knock Out Ò , a sport of Knock Out Ò , was susceptible to Race 8. Partial resistance rank for LL was generally consistent across races for roses susceptible to multiple races. The application of these data includes: characterizing the minimum resistance level needed for roses to warrant inclusion in Earth-Kind field trials, the identification of additional race-specific resistance genes, identifying resistance-breaking isolates of D. rosae, understanding race composition in field trials based on infection patterns of key cultivars, selection of parents for resistance breeding efforts, and continued comparisons between LL and growing bodies of Earth-Kind field resistance data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.